BlackRock Advisors’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$1.5M Buy
123,763
+948
+0.8% +$11.5K ﹤0.01% 1596
2016
Q3
$1.13M Buy
122,815
+1,115
+0.9% +$10.2K ﹤0.01% 1713
2016
Q2
$1.16M Sell
121,700
-1,930
-2% -$18.3K ﹤0.01% 1664
2016
Q1
$872K Buy
123,630
+1,502
+1% +$10.6K ﹤0.01% 1769
2015
Q4
$1.28M Sell
122,128
-63,655
-34% -$666K ﹤0.01% 1580
2015
Q3
$1.24M Buy
185,783
+11,187
+6% +$74.8K ﹤0.01% 1538
2015
Q2
$1.17M Sell
174,596
-68,966
-28% -$463K ﹤0.01% 1523
2015
Q1
$1.65M Sell
243,562
-2,306
-0.9% -$15.6K ﹤0.01% 1277
2014
Q4
$1.97M Sell
245,868
-3,571
-1% -$28.6K ﹤0.01% 1181
2014
Q3
$878K Buy
249,439
+1,573
+0.6% +$5.54K ﹤0.01% 1486
2014
Q2
$1.19M Sell
247,866
-31,363
-11% -$150K ﹤0.01% 1365
2014
Q1
$2.65M Sell
279,229
-7,330
-3% -$69.6K ﹤0.01% 1091
2013
Q4
$1.86M Buy
286,559
+269,501
+1,580% +$1.75M ﹤0.01% 1193
2013
Q3
$129K Buy
+17,058
New +$129K ﹤0.01% 2792